Why Insys Therapeutics, Inc. Shares Skyrocketed

Insys shares skyrocket after a better-than-expected fourth-quarter report. Can Insys shares head even higher or has it hit a plateau?

Mar 4, 2014 at 1:22PM

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Insys Therapeutics (NASDAQ:INSY), a biopharmaceutical company focused on developing therapies for cancer-supportive care, rocketed higher by as much as 27% after reporting much better-than-expected fourth-quarter results.

So what: For the quarter, Insys delivered $40.2 million in revenue, a 673% increase over the year-ago quarter, as Subsys, the company's FDA-approved treatment for breakthrough cancer pain, saw its revenue climb to $39.2 million. This alone was a 38% increase over the sequential third quarter. Adjusted profit rose to $0.71 per share relative to a $0.59-per-share loss in the corresponding quarter in 2012. By comparison, Wall Street had expected just $34.7 million in revenue and $0.55 in EPS, so Insys absolutely crushed estimates. The company's press release also notes that it plans to file for at least one new drug application and four investigational new drug applications in 2014.

Now what: At the moment, the correlation is pretty clear: Insys' success is wholly dependent on the rapid growth and acceptance of its cancer pain med Subsys. It's difficult to ignore 38% quarterly sequential growth, but with Insys' share price up more than 650% from its 52-week low, it could also give investors reason for pause as well. I would suggest, even at 44 times forward earnings, that Insys could still have further upside given its gross margin, which is nearing 90%, its growing pipeline, and the fact that the Street appears to have underestimated Subsys' peak potential. I wouldn't go so far as to suggest it has another 650% run up its sleeve, but I could see shares moving modestly higher over the next couple of years on Subsys' growth as well as the advancement of key pipeline therapies.

Insys may be up huge over the past year, but even it may struggle to keep up with this top stock moving forward
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

The Motley Fool has no position in any companies mentioned in this article. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

A Financial Plan on an Index Card

Keeping it simple.

Aug 7, 2015 at 11:26AM

Two years ago, University of Chicago professor Harold Pollack wrote his entire financial plan on an index card.

It blew up. People loved the idea. Financial advice is often intentionally complicated. Obscurity lets advisors charge higher fees. But the most important parts are painfully simple. Here's how Pollack put it:

The card came out of chat I had regarding what I view as the financial industry's basic dilemma: The best investment advice fits on an index card. A commenter asked for the actual index card. Although I was originally speaking in metaphor, I grabbed a pen and one of my daughter's note cards, scribbled this out in maybe three minutes, snapped a picture with my iPhone, and the rest was history.

More advisors and investors caught onto the idea and started writing their own financial plans on a single index card.

I love the exercise, because it makes you think about what's important and forces you to be succinct.

So, here's my index-card financial plan:


Everything else is details. 

Something big just happened

I don't know about you, but I always pay attention when one of the best growth investors in the world gives me a stock tip. Motley Fool co-founder David Gardner (whose growth-stock newsletter was rated #1 in the world by The Wall Street Journal)* and his brother, Motley Fool CEO Tom Gardner, just revealed two brand new stock recommendations moments ago. Together, they've tripled the stock market's return over 12+ years. And while timing isn't everything, the history of Tom and David's stock picks shows that it pays to get in early on their ideas.

Click here to be among the first people to hear about David and Tom's newest stock recommendations.

*"Look Who's on Top Now" appeared in The Wall Street Journal which references Hulbert's rankings of the best performing stock picking newsletters over a 5-year period from 2008-2013.

Compare Brokers